Explore the words cloud of the CRYOSTEM project. It provides you a very rough idea of what is the project "CRYOSTEM" about.
The following table provides information about the project.
THE UNIVERSITY OF WARWICK
|Coordinator Country||United Kingdom [UK]|
|Total cost||150˙000 €|
|EC max contribution||150˙000 € (100%)|
1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
|Duration (year-month-day)||from 2018-06-01 to 2019-11-30|
Take a look of project's partnership.
|1||THE UNIVERSITY OF WARWICK||UK (COVENTRY)||coordinator||150˙000.00|
This proof of concept grant will revolutionise how bone marrow stem cells are cryopreserved by translating ERC-grant developed technology, inspired by how organisms survive in extreme cold temperatures. Bone marrow (haematopoietic) stem cells are used in life saving treatments, especially for blood cancers such as Leukaemia, but have potential for a wide range of diseases. The current method for storing stem cells involves addition of huge amounts of toxic organic solvents which leads to unwanted side-effects and not all the recovered cells are viable. There is also a rapidly growing market for stem-cell therapies, but with a major bottleneck being the logistics of transport: getting the cells from the (small number of) specialised production facilities to the patients, with minimum processing and within the cold chain. We have established strong preliminary data demonstrating an entirely new concept in cryopreservation based on the use of (patent pending) synthetic polymers, which can control ice formation and growth. These are inspired by how antifreeze proteins protect organisms which live in sub-zero environments, but with the advantages of being; Highly tuneable; Low toxicity; Scalable synthesis. This is backed up by demonstration of function in immortalised cell lines, and is ready to be applied to real biomedical problems. In this project we will obtain convincing data-sets demonstrating that our synthetic polymer can revolutionise the storage and transport of stem cells for current and emerging therapies. This will bring significant societal change through enabling new regenerative medicine therapies and bringing real commercial benefit by solving a supply chain challenge and improving on the current 50 year old method.
|year||authors and title||journal||last update|
Christopher Stubbs, Trisha L. Bailey, Kathryn Murray, Matthew I. Gibson
Polyampholytes as Emerging Macromolecular Cryoprotectants
published pages: , ISSN: 1525-7797, DOI: 10.1021/acs.biomac.9b01053
Caroline I. Biggs, Christopher Stubbs, Ben Graham, Alice E. R. Fayter, Muhammad Hasan, Matthew I. Gibson
Mimicking the Ice Recrystallization Activity of Biological Antifreezes. When is a New Polymer â€œActiveâ€?
published pages: 1900082, ISSN: 1616-5187, DOI: 10.1002/mabi.201900082
|Macromolecular Bioscience Volume19, Issue7 July 2019||2019-11-07|
Laura E. Wilkins, Muhammad Hasan, Alice E. R. Fayter, Caroline Biggs, Marc Walker, Matthew I. Gibson
Site-specific conjugation of antifreeze proteins onto polymer-stabilized nanoparticles
published pages: 2986-2990, ISSN: 1759-9954, DOI: 10.1039/c8py01719k
|Polymer Chemistry 10/23||2019-11-07|
Trisha L. Bailey, Christopher Stubbs, Kathryn Murray, Ruben M. F. TomÃ¡s, Lucienne Otten, Matthew I. Gibson
Synthetically Scalable Poly(ampholyte) Which Dramatically Enhances Cellular Cryopreservation
published pages: 3104-3114, ISSN: 1525-7797, DOI: 10.1021/acs.biomac.9b00681
Collette S. Guy, Kathryn Murray, Matthew I. Gibson, Elizabeth Fullam
Dimeric benzoboroxoles for targeted activity against Mycobacterium tuberculosis
published pages: , ISSN: 1477-0520, DOI: 10.1039/c9ob02222h
|Organic & Biomolecular Chemistry Org. Biomol. Chem., 2019, Advan||2019-11-07|
Ruben M. F. TomÃ¡s, Matthew I. Gibson
Optimization and Stability of Cellâ€“Polymer Hybrids Obtained by â€œClickingâ€ Synthetic Polymers to Metabolically Labeled Cell Surface Glycans
published pages: 2726-2736, ISSN: 1525-7797, DOI: 10.1021/acs.biomac.9b00478
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CRYOSTEM" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "CRYOSTEM" are provided by the European Opendata Portal: CORDIS opendata.